Virometix closes extension financing round
Zurich, Switzerland (November 19, 2014)
– Virometix today announced that it has closed an extension to its recent financing round. Virometix will use the proceeds to further speed up the development of its vaccine candidates for infectious and viral diseases.
Virometix moves to a new location
Zurich-Schlieren, Switzerland (July 21, 2014)
– Virometix today announced relocation of its operations to new premises in order to better meet the business needs of the company. The new office is located at the BIO-TECHNOPARK Zurich–Schlieren, which hosts a cluster of life science companies ranging from recent University spin-offs to leading global pharmaceutical companies.